Skip to main content
Hit enter to search or ESC to close
Close Search
Seawolf TherapeuticsSeawolf TherapeuticsSeawolf Therapeutics
Menu
  • About
  • Technology
  • News
  • Careers
  • Contact
    Water Background

    News1

    Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics News

    Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics

    Series A financing by Versant Ventures, MPM BioImpact, Novartis Venture Fund, Eli Lilly and Company, CRISPR Therapeutics AG, and others
    fefifolios
    fefifoliosNovember 16, 2026

    9880 Campus Point Drive, Suite 210
    San Diego, CA 92121

    (858) 257-3478

    © 2026 Seawolf Therapeutics. - Privacy Policy

    • linkedin
    Close Menu
    • About
    • Technology
    • News
    • Careers
    • Contact
    • linkedin